Author:
Reuters
article author:
Reuters
ID:
1601033957232129000
Fri, 2020-09-25 11:33
LONDON: Generic drugmaker Endo said on Friday it was manufacturing Novavax Inc’s experimental COVID-19 vaccine, sending its shares up 10% before the trading bell.
The news comes a day after Novavax launched a late-stage trial of the vaccine candidate, NVX-CoV2373, in the United Kingdom.
Endo said it has signed a deal with Novavax and its unit Par Sterile has begun production of the final drug product, with initial batches to be used in Novavax’s phase-3 clinical trial in the United States.

Main category:
World
Tags:
Endo
Novavax
Coronavirus
vaccine
مزيد من التفاصيل